NCT06607185 2026-04-22A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT07020221 2026-04-22A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsVerastem, Inc.Phase 1/2 Recruiting295 enrolled
NCT06561685 2026-04-20A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Recruiting340 enrolled
NCT05382559 2026-04-14A Study of ASP3082 in Adults With Advanced Solid TumorsAstellas Pharma IncPhase 1 Recruiting681 enrolled
NCT04205812 2026-03-31POD1UM-304Incyte CorporationPhase 3 Active not recruiting583 enrolled 22 charts